Anti-HPV16 L1/Major capsid protein L1 Antibody (SAA2553)

Anti-HPV16 L1/Major capsid protein L1 Antibody (SAA2553)

A powerful tool for your biotech research needs.

This highly specific antibody targets the L1 protein of the human papillomavirus type 16 (HPV16), a known cause of cervical cancer. By binding to the L1 protein, it effectively blocks the virus from entering host cells, making it an essential tool for studying HPV16 and its role in cancer development.

With its high affinity and specificity, this antibody is ideal for use in various applications, including Western blotting, immunofluorescence, and immunohistochemistry. It has been extensively tested and validated for use in both in vitro and in vivo experiments, ensuring reliable and reproducible results.

In addition to its use in basic research, this antibody also has potential therapeutic applications. By targeting the L1 protein, it has the potential to prevent HPV16 infection and inhibit the development of cervical cancer.

Some experimental use cases for this antibody include studying the mechanism of HPV16 infection, identifying potential therapeutic targets, and evaluating the efficacy of anti-HPV therapies. Its use in diagnostic assays for HPV16 detection is also being explored.

In summary, the Anti-HPV16 L1/Major capsid protein L1 Antibody (SAA2553) is a valuable tool for researchers studying HPV16 and its implications in cervical cancer. Its high specificity, versatility, and potential therapeutic applications make it a must-have for any biotech laboratory. Order now and take your research to the next level.